Topiramate Tablet, Film Coated
Product Images NDC 71335-9727

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-9727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0ed6c856 4d95 4aeb B925 15346555a2ab 565 2)

FDA Label Image

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 01)

FDA Label Image

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 02)

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 02)
This text appears to be presenting cumulative rates for time to first seizure for two different dosages of Topiramate. The specific dosages are mentioned as Topiramate 50 mg/day and Topiramate 400 mg/day, with corresponding sample sizes of N=234 and N=236 respectively. The text also mentions a p-value of 0.00002, indicating a statistically significant difference between the two dosages. The graph at the end of the text shows time in days on the x-axis and cumulative rates on the y-axis.*
FDA Label Image

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 03)

FDA Label Image

Label (Lbl713359727)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.